Table I.
Nuclear WTAP expression | ||||
---|---|---|---|---|
Variable | Patient number | High | Low | P-valuea |
Genderb | 0.010 | |||
Male | 85 | 37 | 48 | |
Female | 54 | 12 | 42 | |
Age (years) | 0.918 | |||
≥65 | 43 | 15 | 28 | |
<65 | 95 | 34 | 61 | |
Tumor location | 0.851 | |||
Head | 79 | 28 | 51 | |
Non-head | 54 | 20 | 34 | |
Tumor size (cm) | 0.290 | |||
≥4 | 98 | 37 | 61 | |
<4 | 39 | 11 | 28 | |
Histological grade | 0.443 | |||
G1–2 | 106 | 35 | 71 | |
G3–4 | 19 | 8 | 11 | |
T stage | 0.020 | |||
T1–2 | 81 | 22 | 59 | |
T3 | 56 | 26 | 30 | |
N stage | 0.512 | |||
N0 | 78 | 26 | 52 | |
N1 | 54 | 21 | 33 | |
PNI | 0.687 | |||
Present | 69 | 26 | 43 | |
Absent | 31 | 13 | 18 |
χ2 test. Total patient number does not equal 145 in all categories, as patient information was not available for all cases. WTAP, Wilms tumor 1-associated protein; G1, well-differentiated; G2, moderately-differentiated; G3, poorly-differentiated; G4, undifferentiated; T, tumor; N, lymph node; PNI, perineural invasion.